Santen Pharmaceutical

Santen Pharmaceutical, founded in 1890 by Kenkichi Taguchi as Taguchi Santendo, is a Japanese pharmaceutical company specializing exclusively in ophthalmology. It holds the leading market share for ophthalmic products within Japan and is recognized as one of the premier global companies in this specialized medical field. With a history spanning over a century, Santen Pharmaceutical has consistently focused on advancing eye care solutions, extending its reach to over 50 countries worldwide.

Operating with a dedicated workforce of 1,000 to 5,000 employees across 7 distinct locations, Santen Pharmaceutical generates approximately $2.1B in revenue. This global presence allows the company to develop and distribute innovative ophthalmic treatments. The product portfolio includes a comprehensive range of prescription pharmaceuticals, specialty ophthalmic drugs, and advanced drug delivery systems aimed at treating various eye diseases and supporting long-term vision health. Meet Santen Pharmaceutical's team to gain insight into the expertise driving their commitment to ocular well-being.

Within the Healthcare and Pharmaceuticals industries, Santen Pharmaceutical's core business revolves around delivering high-quality eye care. Its offerings encompass treatments for a spectrum of ocular conditions, emphasizing early detection, effective mechanisms, and comprehensive life cycle management for its pharmaceutical products. The company's enduring mission, rooted in its 1890 establishment, is to contribute to human well-being by providing advanced solutions that enhance eye health and quality of life globally.